Efficacy News and Research

RSS
BROCA test identifies 12 gene mutations linked to ovarian and related cancers

BROCA test identifies 12 gene mutations linked to ovarian and related cancers

Effectiveness of present flu vaccines may not be satisfactory: Study

Effectiveness of present flu vaccines may not be satisfactory: Study

Biogen’s Multiple Sclerosis pill succeeds at a late phase clinical trial

Biogen’s Multiple Sclerosis pill succeeds at a late phase clinical trial

Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research

Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research

CryoLife begins enrollment in BioFoam Surgical Matrix IDE clinical trial

CryoLife begins enrollment in BioFoam Surgical Matrix IDE clinical trial

Synergy commences plecanatide Phase II/III trial in chronic idiopathic constipation

Synergy commences plecanatide Phase II/III trial in chronic idiopathic constipation

FDA accepts Ironwood and Forest Laboratories' linaclotide NDA for review

FDA accepts Ironwood and Forest Laboratories' linaclotide NDA for review

Complexities of DNA repair

Complexities of DNA repair

Femtosecond laser cataract surgery safe and effective than standard procedure

Femtosecond laser cataract surgery safe and effective than standard procedure

Abbott, Biogen Idec announce additional results from daclizumab HYP Phase 2b trial for RRMS

Abbott, Biogen Idec announce additional results from daclizumab HYP Phase 2b trial for RRMS

Sanofi announces new results from alemtuzumab-Rebif comparative CARE-MS I trial

Sanofi announces new results from alemtuzumab-Rebif comparative CARE-MS I trial

Ferring reports on FDA approval of labeling supplement for EUFLEXXA to treat knee osteoarthritis

Ferring reports on FDA approval of labeling supplement for EUFLEXXA to treat knee osteoarthritis

Janssen announces FDA label update approval for PREZISTA HIV tablets

Janssen announces FDA label update approval for PREZISTA HIV tablets

Merz presents XEOMIN clinical data on dystonia at IDS 2011

Merz presents XEOMIN clinical data on dystonia at IDS 2011

Positive top line results from Shire's LDX phase III study on ADHD

Positive top line results from Shire's LDX phase III study on ADHD

Much work remains to be done in fight against malaria

Much work remains to be done in fight against malaria

Boehringer Ingelheim announces new data from hepatitis C virus portfolio

Boehringer Ingelheim announces new data from hepatitis C virus portfolio

Genentech announces 96-week results from ocrelizumab Phase II study on RRMS

Genentech announces 96-week results from ocrelizumab Phase II study on RRMS

Preclinical data from Teva's COPAXONE study on multiple sclerosis

Preclinical data from Teva's COPAXONE study on multiple sclerosis

Young docs not so keen on immunizations: Survey

Young docs not so keen on immunizations: Survey

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.